Tune into this podcast to hear an advanced practice provider and an expert in atopic dermatitis (AD) in an engaging dialogue on the role of newer agents in AD—when they're indicated, how to use them, where they fit on the therapeutic ladder, and adverse effects to monitor for—and get tips on how to individualize therapy and anticipate adherence issues. The podcast concludes with thoughts on how to address some frequently asked questions from patients and caregivers.
After completing this activity, participants should be better able to:
- Develop individualized treatment plans for use of novel therapies in patients with AD
- Apply strategies to promote patient/caregiver engagement with care and increase treatment adherence among patients with AD
Dermatology NPs, PAs, and RNs
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
NP course advisor: Veronica Richardson, MSN, CRNP, ANP-BC, DCNP, University of Pennsylvania, Philadelphia, Pennsylvania
Nursing contact hours: 0.50, which includes 0.50 hours of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until November 14, 2022. PAs should only claim credit commensurate with the extent of their participation.
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credits for learning and change.
This activity is supported by an educational grant from Incyte Corporation.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Ms Maier has no relevant financial relationships to disclose.
Ms Richardson: consulting fees: Boehringer Ingelheim, Lilly.
Dr Sidbury: contracted research: Galderma, Pfizer, Regeneron, UCB; consulting fees: Leo, Lilly; fees for non-CME/CE services: Biersdorf.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose except Dr Richardson, as noted above.
Participants wishing to earn CE/CME credit must:
- Listen to the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.
The estimated time to complete this activity is 0.50 hours.
Release date: November 15, 2021
Expiration date: November 14, 2022
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 103721ADIC